Approval · Notice of Compliance 7232 · 2005
REVALOR-S IMPLANTS: Notice of Compliance 7232
Issued July 14, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7232
- Date
- July 14, 2005
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate source of active ingredient
- Therapeutic class
- Growth promotant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REVALOR-S IMPLANTS | 02078589 | Marketed |
Medicinal ingredients
- TRENBOLONE ACETATE 120 MG per IMP
- ESTRADIOL 24 MG per IMP